Advertisement

Topics

India's Glenmark signs license agreement for APC Therapeutics’ small molecule oncology compound

19:00 EDT 21 Jun 2017 | Pharmaceutical Technology

India-based Glenmark Pharmaceuticals has entered a licensing agreement with US company APC Therapeutics for exclusive rights to a small molecule, oncology compound based on antigen presenting cell (APC) biology.

Original Article: India's Glenmark signs license agreement for APC Therapeutics’ small molecule oncology compound

NEXT ARTICLE

More From BioPortfolio on "India's Glenmark signs license agreement for APC Therapeutics’ small molecule oncology compound"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...